ÂÜÀòÂÒÂ×

Alan Tucholka is an accomplished professional in the field of neuroimaging and artificial intelligence, currently serving as the Chief Technology Officer at Sama Therapeutics since June 2023, where efforts focus on advancing neuropsychiatry through AI-powered solutions. Previously, Alan held the position of Chief Scientific Officer at Pixyl Medical, managing R&D teams and spearheading AI developments to strategically address clinical challenges. Alan's expertise is supported by a robust research background, including roles as a Postdoctoral Researcher at the BarcelonaBeta Brain Research Center, where significant contributions were made to Alzheimer's disease biomarker discovery, and as a Research Coordinator in Neuroimaging at the Centre hospitalier de l'Université de Montréal. Alan holds a Ph.D. and a Master's degree in Computer Science with a concentration in Neuroimaging from Paris-Sud University.